Table 1.
Local vascular volumes (μl (g dry wt)−1) and water content (ml (g dry wt)−1) in skin and muscle
| No rolipram + volume expansion | Rolipram + volume expansion | Non-expanded control (n = 24) | |
|---|---|---|---|
| Vascular volume | |||
| Back skin | 8.8 ± 0.9 (n = 8) | 8.7 ± 0.7 (n = 10) | 9.0 ± 0.8 |
| Tail skin | 23.8 ± 4.0 (n = 10) | 26.1 ± 2.2 (n = 11) | 24.9 ± 2.1 |
| Hamstring muscle | 30.7 ± 2.31 (n = 9) | 33.8 ± 2.21 (n = 11) | 22.9 ± 1.1 |
| Quadriceps muscle | 24.8 ± 1.01 (n = 9) | 32.7 ± 1.61,2 (n = 11) | 16.1 ± 0.9 |
| Water content | |||
| Back skin | 1.79 ± 0.03 (n = 10) | 1.79 ± 0.04 (n = 11) | 1.79 ± 0.12 |
| Tail skin | 1.78 ± 0.04 (n = 10) | 1.71 ± 0.03 (n = 11) | 1.84 ± 0.04 |
| Hamstring muscle | 4.26 ± 0.08 (n = 10) | 4.18 ± 0.07 (n = 11) | 4.01 ± 0.08 |
| Quadriceps muscle | 4.35 ± 0.091 (n = 10) | 4.40 ± 0.081 (n = 11) | 4.07 ± 0.04 |
P < 0.05
1
when compared to Non-expanded control with one-way ANOVA
2
when compared to No rolipram + volume expansion with one-way ANOVA.